CITCCA data demonstrate more than 40% of high-risk stage I–III colorectal patients harbor molecular residual disease at clinical landmark, detectable only with ultrasensitive ctDNA testingMORRISVILLE, ...

The hospital believes that medicine should not only treat the ill but also help people maintain their health. This trend ...

Helio Genomics announced a partnership with Ohio-based LiverRight Inc. to integrate its new early liver cancer detection test ...

Genomics, Inc. , a leader in single cell and spatial biology, today announced a collaboration with Brigham & Women's Hospital, a world-class academic medical center, to analyze peripheral blood ...

As individuals, we can’t do much about microplastics. A lot of it ends up in the oceans, the fish are ingesting it and we’re ...

Freenome today announced an initiative to advance its blood-based early cancer screening program by leveraging NVIDIA deep learning technology and expertise to improve the recognition of ...

To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical ...

The Tuesday, January 13, spoilers for Beyond the Gates focus on Anita and Vernon. Now that Anita’s first chemo treatment is ...

Retinoic acid suppresses immune defenses against cancer, but a new drug KyA33 boosts vaccine success and slows tumor growth ...

For more than 25 years, humans have lived and worked continuously aboard the International Space Station, conducting research ...

Explore innovative Type 2 diabetes drugs that enhance insulin sensitivity and reduce side effects from older treatments.

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...